The team at the Brain Tumour Research Centre of Excellence at Imperial College London has welcomed a new researcher funded by the charity.
Dr Sophie Morse received her PhD in Bioengineering from Imperial College in 2020. With her research, she has improved the way drugs are delivered to the brain using a non-invasive and targeted ultrasound technology combined with microbubbles. Now being funded by Brain Tumour Research, she will apply this ultrasound technique to the field of brain sciences, specifically to brain tumours.
Sophie has won numerous awards for her work, including the Gold Medal in Engineering at the STEM for Britain event in the UK Parliament, Young Investigator Awards from the British and European Ultrasound Societies, and the William James Award from the Institute of Engineering and Technology.
Our Head of Stakeholder Relations, Hugh Adams, said: “We extend a warm welcome to Sophie as she joins the pioneering team at our Imperial College Research Centre.
“Focused ultrasound is an exciting area of brain tumour research, offering a targeted, less-invasive way to cross the blood brain barrier for more effective drug delivery to the brain. This research, which could improve outcomes and treatments, brings hope to brain tumour patients and their loved ones.”
- New approaches to removing brain tumours safely and effectively at our Imperial Research Centre
- Our Centre of Excellence at Imperial College London
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.